Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by AngelMan92on Jul 11, 2020 2:14pm
101 Views
Post# 31255766

RE:Let's get all into perspective

RE:Let's get all into perspectiveAnd this is not including any offers that are coming from any of the affiliated companies in partnership with Stage like Ichor, who is actually selling their tests for more expensive :))
AngelMan92 wrote: Okay so, we've learned alot in the past week. - News agencies are stating that the number of testing companies all together cannot meet the demand for testing. - Stage is offering Antibody tests for 75$ minimum and their PCR (which is the majority of their orders) for 220$/test. - Rebecca stated that they are actually at capacity. With all this in mind, we can derive that if 75% of the tests are PCR. Our 250,000 test order is a potential revenue of 46 MILLION US DOLLARS. Keep in mind this is without any news of what happened after mass expansion, where the current order count is at, or anything. We are gonna be rich :D ABC News 1 day ago 13 states now report coronavirus testing issues, in echo of early troubles https://www.google.com/url?sa=t&source=web&rct=j&url=https://abcnews.go.com/amp/Health/13-states-now-report-coronavirus-testing-issues-echo/story%3Fid%3D71698974&ved=2ahUKEwj7mouX4sXqAhUloHIEHU1iDOAQiJQBMAB6BAgJEAQ&usg=AOvVaw0ppRyea6atLiopy862Tp_2&cf=1&cshid=1594490094973


Bullboard Posts